Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pan, M.
Right arrow Articles by Souba, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan, M.
Right arrow Articles by Souba, W.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:2826S-2829S, October 2004


Supplement: Arginine Metabolism: Enzymology, Nutrition, and Clinical Significance

Arginine Transport in Catabolic Disease States1,2

Ming Pan, Haroon A. Choudry, Mark J. Epler, QingHe Meng, Anne Karinch, ChengMao Lin and Wiley Souba3

Department of Surgery at the Penn State College of Medicine and the Hershey Medical Center, Hershey, PA 17033

3To whom correspondence should be addressed. E-mail: wsouba{at}psu.edu.

Arginine appears to be a semiessential amino acid in humans during critical illness. Catabolic disease states such as sepsis, injury, and cancer cause an increase in arginine utilization, which exceeds body production, leading to arginine depletion. This is aggravated by the reduced nutrient intake that is associated with critical illness. Arginine depletion may have negative consequences on tissue function under these circumstances. Nutritional regimens containing arginine have been shown to improve nitrogen balance and lymphocyte function, and stimulate arginine transport in the liver. We have studied the effects of stress mediators on arginine transport in vascular endothelium, liver, and gut epithelium. In vascular endothelium, endotoxin stimulates arginine uptake, an effect that is mediated by the cytokine tumor necrosis factor-{alpha} (TNF-{alpha}) and by the cyclo-oxygenase pathway. This TNF-{alpha} stimulation involves the activation of intracellular protein kinase C (PKC). A significant increase in hepatic arginine transport activity also occurs following burn injury and in rats with progressive malignant disease. Surgical removal of the growing tumor results in a normalization of the accelerated hepatic arginine transport within days. Chronic metabolic acidosis and sepsis individually augment intestinal arginine transport in rats and Caco-2 cell culture. PKC and mitogen-activated protein kinases are involved in mediating the sepsis/acidosis stimulation of arginine transport. Understanding the regulation of plasma membrane arginine transport will enhance our knowledge of nutrition and metabolism in seriously ill patients and may lead to the design of improved nutritional support formulas.


KEY WORDS: • arginine • membrane transport • catabolism




This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Zhou and R. G. Martindale
Arginine in the Critical Care Setting
J. Nutr., June 1, 2007; 137(6): 1687S - 1692S.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. D. Peluffo
L-Arginine currents in rat cardiac ventricular myocytes
J. Physiol., May 1, 2007; 580(3): 925 - 936.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by American Society for Nutrition